Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit B4 pseudogene 7 (NDUFB4P7) is a human pseudogene similar in sequence to the NADH:ubiquinone oxidoreductase subunit B4 gene, located on chromosome X[1][3]. Pseudogenes like NDUFB4P7 do not encode functional proteins, but may exert biological activity at the RNA level by acting as decoys for microRNAs, thus influencing the expression of their protein-coding gene counterparts[5]. There is currently no evidence that NDUFB4P7 serves as a therapeutic target, receptor, enzyme, or transporter. No known drugs, biomarkers, or safety issues are associated with this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 7 (NDUFB4P7).